Walleye Capital LLC Rvl Pharmaceuticals PLC Transaction History

Walleye Capital LLC

  • $54.3 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$4.82 - $8.77 $123,874 - $225,389
-25,700 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$2.83 - $6.99 $72,731 - $179,643
25,700 New
25,700 $173,000
Q1 2020

May 15, 2020
SELL
$3.18 - $7.0 $98,898 - $217,700
-31,100 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$3.46 - $7.7 $107,606 - $239,470
31,100 New
31,100 $217,000

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0
View Full List

About RVL Pharmaceuticals plc

RVLP Quotes by TradingView
  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email